Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:CCEL NASDAQ:DHAC OTCMKTS:PCHM OTCMKTS:TNTY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCCELCryo-Cell International$4.88-2.2%$5.05$4.75▼$9.43$39.43M0.6413,107 shs5,790 shsDHACDigital Health Acquisition$1.17-1.7%$1.16$11.07▼$33.08$4.22M0.2340,215 shs7,770 shsPCHMPharmChem$3.90+0.3%$3.56$2.85▼$3.95$18.14M0.775,733 shs145 shsTNTYTrue Nature$0.34-3.5%$0.33$0.02▼$0.11$29.24M2.99785,609 shs5,128 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCCELCryo-Cell International+1.84%-1.58%-3.85%-4.95%-5.13%DHACDigital Health Acquisition0.00%+6.36%+2.63%+2.63%-86.79%PCHMPharmChem+2.10%+1.83%+4.01%+30.54%+11.46%TNTYTrue Nature0.00%+20.64%-3.15%-22.70%+17.05%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCCELCryo-Cell International3.3655 of 5 stars3.55.01.70.00.01.70.0DHACDigital Health AcquisitionN/AN/AN/AN/AN/AN/AN/AN/APCHMPharmChemN/AN/AN/AN/AN/AN/AN/AN/ATNTYTrue NatureN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCCELCryo-Cell International 3.00Buy$8.5074.18% UpsideDHACDigital Health Acquisition 0.00N/AN/AN/APCHMPharmChem 0.00N/AN/AN/ATNTYTrue Nature 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCCELCryo-Cell International$31.99M1.23$0.18 per share27.34($1.64) per share-2.98DHACDigital Health AcquisitionN/AN/AN/AN/AN/AN/APCHMPharmChem$6.09M2.98N/AN/AN/A∞TNTYTrue NatureN/AN/AN/AN/A($0.03) per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCCELCryo-Cell International$400K-$1.06488.49∞N/A0.40%-1.07%0.20%N/ADHACDigital Health AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/APCHMPharmChem$1.38M$0.3212.19∞N/A24.02%N/AN/A8/5/2025 (Estimated)TNTYTrue Nature-$3.88MN/A0.00∞N/AN/AN/A-13,987.90%N/ALatest PCHM, CCEL, TNTY, and DHAC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/9/2025Q1 2025PCHMPharmChemN/A$0.06N/A$0.06N/A$1.58 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCCELCryo-Cell International$0.6012.30%N/AN/A N/ADHACDigital Health AcquisitionN/AN/AN/AN/AN/APCHMPharmChemN/AN/AN/AN/AN/ATNTYTrue NatureN/AN/AN/AN/AN/ALatest PCHM, CCEL, TNTY, and DHAC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/8/2025CCELCryo-Cell Internationalquarterly$0.1511.79%5/21/20255/30/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCCELCryo-Cell InternationalN/A0.580.54DHACDigital Health AcquisitionN/AN/AN/APCHMPharmChemN/AN/AN/ATNTYTrue NatureN/A0.040.04Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCCELCryo-Cell International10.44%DHACDigital Health Acquisition1.01%PCHMPharmChemN/ATNTYTrue NatureN/AInsider OwnershipCompanyInsider OwnershipCCELCryo-Cell International36.86%DHACDigital Health Acquisition6.59%PCHMPharmChem17.40%TNTYTrue Nature30.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCCELCryo-Cell International908.08 million5.10 millionNot OptionableDHACDigital Health Acquisition2,0213.60 million3.37 millionNot OptionablePCHMPharmChem1704.65 million3.84 millionNot OptionableTNTYTrue Nature3086.57 millionN/ANot OptionablePCHM, CCEL, TNTY, and DHAC HeadlinesRecent News About These CompaniesIs “Animal Kingdom” based on a true story? Meet the real-life crime family that inspired the hit showJune 17, 2025 | msn.comTop 20 actors who hate being famousNovember 14, 2024 | soapcentral.comSResilience in the face of nature: An Oklahoma rancher's daily struggle with the elementsNovember 14, 2024 | ktul.comKWhy is Jake Paul vs Mike Tyson on Netflix? What fight means for future of live sportNovember 13, 2024 | msn.comChinese man cycles across the US to ‘show that human nature is good'November 9, 2024 | nbclosangeles.comNInter vs Arsenal LIVE: Champions League result and reaction as Hakan Calhanoglu penalty proves decisiveNovember 7, 2024 | msn.comThe Completely Free Nature Center Hiding in an Oklahoma State Park Is a Must-VisitNovember 6, 2024 | onlyinyourstate.comOSouth Carolina women's basketball bold predictions includes national tile, SEC MVP MiLaysia FulwileyNovember 4, 2024 | greenvilleonline.comGInvest in ethical hunting and recreation for the true balance of natureNovember 3, 2024 | durangoherald.comDAI in wrong hands can cause annihilation beyond imagination, says WHO AdvisorNovember 3, 2024 | msn.comGeorge Ford misses two last-gasp kicks in England’s agonising defeat by New ZealandNovember 3, 2024 | telegraph.co.ukWhat is a Conservative? Understanding how the term works in American politicsNovember 1, 2024 | thenewstribune.comTTrump heads West for back-to-back rallies, Harris campaigns with Obama and Springsteen as race tightensOctober 30, 2024 | cbsnews.comKyrie Irving's expertise in key area shows why he's perfect for MavericksOctober 30, 2024 | msn.comThe best shows on Peacock right now (November 2024)October 30, 2024 | msn.comJulia Leigh’s The Hunter at 25: a ruthlessly unsentimental tale of nature betrayedOctober 29, 2024 | theconversation.comT10 Smallest Motorcycles You Can Buy In 2024October 27, 2024 | topspeed.comT“Disrespectful”: Charles Barkley Falls Prey to Public Scrutiny After Honest Shai Gilgeous-Alexander TakeOctober 26, 2024 | msn.comWant genuine progress toward restoring nature? Follow these four stepsOctober 26, 2024 | msn.comWhat will be the next chapter of Justin Brownlee's legend?October 24, 2024 | espn.inENew MarketBeat Followers Over TimeTop HeadlinesView All HeadlinesIntel's Turnaround Strategy Shifts From Planning to Attack ModeBy Jeffrey Neal Johnson | June 20, 2025View Intel's Turnaround Strategy Shifts From Planning to Attack Mode3 Catalysts in 7 Days: Archer's Growth Story Just AcceleratedBy Jeffrey Neal Johnson | June 18, 2025View 3 Catalysts in 7 Days: Archer's Growth Story Just AcceleratedGovernment Mandate Sends eVTOL Stocks FlyingBy Jeffrey Neal Johnson | June 10, 2025View Government Mandate Sends eVTOL Stocks FlyingAMD Accelerates Stack Development: Share Price to FollowBy Thomas Hughes | June 16, 2025View AMD Accelerates Stack Development: Share Price to FollowOracle Stock Boils Higher, $300 Price Target in SightBy Thomas Hughes | June 25, 2025View Oracle Stock Boils Higher, $300 Price Target in SightPCHM, CCEL, TNTY, and DHAC Company DescriptionsCryo-Cell International NYSEAMERICAN:CCEL$4.88 -0.11 (-2.20%) As of 02:28 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.Digital Health Acquisition NASDAQ:DHAC$1.17 -0.02 (-1.68%) As of 07/3/2025Digital Health Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on technology and healthcare focused businesses. Digital Health Acquisition Corp. was incorporated in 2021 and is based in Boca Raton, Florida.PharmChem OTCMKTS:PCHM$3.90 +0.01 (+0.26%) As of 02:14 PM EasternPharmChem, Inc. provides PharmChek Sweat Patch that is used to detect drugs of abuse. Its PharmChek Sweat Patch uses sweat as the source and offers alternative to urine testing for cocaine, opiates, amphetamines, PCP, and marijuana. The company was incorporated in 2000 and is based in Fort Worth, Texas.True Nature OTCMKTS:TNTY$0.34 -0.01 (-3.49%) As of 07/3/2025True Nature Holding, Inc. focuses on engaging in compounding pharmacy activities direct to consumers, doctors, and veterinary professionals. It also focuses on the development of software applications in the healthcare arena, including telemedicine; and consideration of services offering using blockchain encryption technology for various aspects of the healthcare industry. The company is based in Atlanta, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SoundHound Rises as Short Sellers Exit and AI Demand Grows Amazon's Prime Day Pullback Meets Bullish Golden Cross Signal Palantir’s Revenue Surge to $1B: Growth vs. Valuation Chime Financial: Analysts Ring In—And It’s a Buy Is Fortinet Ready to Break Out After Months of Consolidation? Robinhood Stock Gets 5 Price Target Upgrades, Signaling Upside AST SpaceMobile: Is Market Noise Drowning Out a $100M Signal? CoreWeave's $9 Billion Power Play for Core Scientific Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
